Endocrine Abstracts

Glucagon-like peptide 1 (GLP1) acts as both a peripheral incretin hormone and a central neuropeptide to regulate glucose and energy homeostasis. Within the brain, GLP1 is synthesised by a discrete collection of neurones in the brainstem, and presynaptic release of GLP1 results in binding to postsynaptic GLP1 receptors (GLP1R). The pattern of projections from these GLP1 synthesising neurones in the mouse brain has been described previously1,2. Here we use a novel tra...

Introduction: Enteroendocrine cells (EECs) are hormone-secreting cells within the intestinal epithelium that play an important role in regulating food absorption, insulin secretion and appetite. To understand the molecular mechanism governing the function of EECs, it is important to investigate cell-type-specific gene expression. The aim of this study was to identify the transcriptome of human EEC populations from organoid culture.Methods: To label the f...

Glucagon like peptide-1 (GLP-1) is derived from selective cleavage of the preproglucagon (PPG) molecule synthesised in intestinal L-cells. The physiological action of GLP-1 is most commonly recognised as a peripherally released incretin, but a subset of neurons in the lower brainstem, the PPG neurons, also express GLP-1. The majority of PPG neuronal cell bodies are located in the nucleus of the solitary tract and their axons project to numerous sites throughout the CNS. Many o...

Backgrounds and aims: Enteroendocrine cells (EECs) are hormone-secreting cells within the intestinal epithelium that play an important role in regulating food absorption, insulin secretion and appetite. The somatostatin (SST)-producing D-cell is an EEC of particular interest due to the profound inhibition exerted by SST over other EECs, highlighting D-cells as critical regulator of the enteroendocrine axis. The aim of this study was to profile the transcriptom...

Background: Glucagon-like peptide 1 (GLP-1) is an incretin hormone released from enteroendocrine L-cells in the gut. GLP-1 analogues and dipeptidyl-peptidase-4 inhibitors are currently used to treat type-2 diabetes. A greater understanding of the mechanisms underlying the release of GLP-1 may facilitate the development of therapeutics to stimulate the release of endogenous GLP-1. Bile acids have been shown to induce GLP-1 release via the G protein-coupled bile acid receptor 1 ...

Objective: Motilin is a proximal small intestinal hormone with roles in gastrointestinal motility, gallbladder emptying and hunger initiation. The molecular mechanisms underlying motilin release in response to fats, bile and duodenal acidification are poorly understood, in part due a lack of suitable cellular and rodent models. We therefore generated a novel human intestinal organoid model with fluorescently labelled motilin-expressing M-cells, which we used to establish the k...